Precision Optics Corporation, Inc. Common stock (POCI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Precision Optics Corporation, Inc. Common stock stock (POCI) is currently trading at $4.49. Precision Optics Corporation, Inc. Common stock PS ratio (Price-to-Sales) is 1.39. WallStSmart rates POCI as Sell.
- POCI PE ratio analysis and historical PE chart
- POCI PS ratio (Price-to-Sales) history and trend
- POCI intrinsic value — DCF, Graham Number, EPV models
- POCI stock price prediction 2025 2026 2027 2028 2029 2030
- POCI fair value vs current price
- POCI insider transactions and insider buying
- Is POCI undervalued or overvalued?
- Precision Optics Corporation, Inc. Common stock financial analysis — revenue, earnings, cash flow
- POCI Piotroski F-Score and Altman Z-Score
- POCI analyst price target and Smart Rating
Precision Optics Corporation, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Precision Optics Corporation, Inc. Common stock (POCI) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, revenue growth. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Precision Optics Corporation, Inc. Common stock (POCI) Key Strengths (2)
Revenue surging 62.80% year-over-year
Paying $1.39 for every $1 of annual revenue
Supporting Valuation Data
Precision Optics Corporation, Inc. Common stock (POCI) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Premium pricing at 3.6x book value
Moderate institutional interest at 34.28%
Precision Optics Corporation, Inc. Common stock (POCI) Detailed Analysis Report
Overall Assessment
This company scores 32/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth, Price/Sales. Valuation metrics including Price/Sales (1.39) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 62.80%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (3.57) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -73.60%, Operating Margin at -23.60%, Profit Margin at -28.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -73.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 62.80% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
POCI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
POCI's Price-to-Sales ratio of 1.39x trades 26% below its historical average of 1.86x (54th percentile). The current valuation is 75% below its historical high of 5.47x set in Jun 2010, and 2670% above its historical low of 0.05x in Jul 2010.
Compare POCI with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Precision Optics Corporation, Inc. Common stock (POCI) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Precision Optics Corporation, Inc. Common stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 24M with 63% growth year-over-year. The company is currently unprofitable, posting a -28.3% profit margin.
Key Findings
Revenue growing at 63% YoY, reaching 24M. This pace significantly outperforms most MEDICAL INSTRUMENTS & SUPPLIES peers.
The company is unprofitable with a -28.3% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -352,421, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Precision Optics Corporation, Inc. Common stock maintain 63%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Precision Optics Corporation, Inc. Common stock.
Bottom Line
Precision Optics Corporation, Inc. Common stock is a high-conviction growth story with revenue accelerating at 63% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -28.3% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:25:05 AM
About Precision Optics Corporation, Inc. Common stock(POCI)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and lighting systems and related components primarily in the United States and the European Economic Area. The company is headquartered in Gardner, Massachusetts.